INJ’s Breakout Potential: $17 Target Eyed as T-Mobile Partnership Fuels Institutional Traction

Injective (INJ) is facing a short-term correction following a strong uptrend driven by institutional interest and the potential of its T-Mobile partnership. Analysts highlight key support levels around $12.25-$12.40, with a failure potentially leading to a retrace towards $11.50-$11.20. However, breaking above $13.00 with high volume could propel INJ toward $14.20-$15.00 and ultimately target $17 as per its inverse head-and-shoulders pattern.